SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-21-050327
Filing Date
2021-10-06
Accepted
2021-10-06 17:05:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1282981
2 GRAPHIC go1xylm23gnk000002.jpg GRAPHIC 7563
3 GRAPHIC go1xylm23gnk000003.jpg GRAPHIC 7563
4 GRAPHIC go1xylm23gnk000001.jpg GRAPHIC 7563
  Complete submission text file 0001564590-21-050327.txt   1315658
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260010 | Film No.: 211310343
SIC: 2834 Pharmaceutical Preparations